The observation that, in the absence of SAP, DGKα is predominantly active, suggests that the signalling defects observed in T cells from XLP-1 patients are in part due to DAG metabolism by DGKα and can be restored by DGKα inhibition (Figure 3A,B). Here, SH2D1A is linked to X-linked lymphoproliferative syndrome.